HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis
Mahasweta Gooptu(Harvard University), Mary Eapen(Medical College of Wisconsin), Edmund K. Waller(Emory University), Natasha Kekre(Ottawa Hospital), Marco Mielcarek(Fred Hutch Cancer Center), Yoshihiro Inamoto, Saurabh Chhabra(Medical College of Wisconsin), Rohtesh S. Mehta(The University of Texas MD Anderson Cancer Center), Claudio G. Brunstein(Hotel Dieu Hospital), Michael R. Grunwald(Levine Cancer Institute), Monzr M. Al Malki(City of Hope), Joseph P. McGuirk(University of Kansas Medical Center), Joseph H. Antin(Dana-Farber Cancer Institute), Mukta Arora(Fairview Health Services), Filippo Milano(Fred Hutch Cancer Center), Rizwan Romee(Washington University in St. Louis), Ephraim J. Fuchs(Johns Hopkins University), Robert J. Soiffer(Dana-Farber Cancer Institute), Nilanjan Ghosh(Levine Cancer Institute), Christopher G. Kanakry(National Cancer Institute), Andrew St. Martin(Johns Hopkins Hospital), Ran Reshef(Abramson Cancer Center), Dipenkumar Modi(Wayne State University), Mark A. Schroeder(MACOM (United States)), Scott R. Solomon(Northside Hospital), Ian McNiece(Clinical Research of South Florida), Christopher Bredeson
Cited by 163
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
|Science Translational Medicine|2016|916
<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
|New England Journal of Medicine|2016|783